SACCHETTI, MARTA
 Distribuzione geografica
Continente #
NA - Nord America 273
AS - Asia 191
EU - Europa 125
Continente sconosciuto - Info sul continente non disponibili 100
SA - Sud America 7
Totale 696
Nazione #
US - Stati Uniti d'America 252
IT - Italia 113
BD - Bangladesh 77
CN - Cina 49
SG - Singapore 28
HK - Hong Kong 27
CA - Canada 11
FR - Francia 4
VN - Vietnam 4
BR - Brasile 3
AR - Argentina 2
CO - Colombia 2
GB - Regno Unito 2
HN - Honduras 2
IN - India 2
JM - Giamaica 2
MX - Messico 2
NL - Olanda 2
PL - Polonia 2
AZ - Azerbaigian 1
CR - Costa Rica 1
DE - Germania 1
EE - Estonia 1
GT - Guatemala 1
ID - Indonesia 1
MY - Malesia 1
NI - Nicaragua 1
PK - Pakistan 1
SV - El Salvador 1
Totale 596
Città #
New York 51
Beijing 37
Hong Kong 27
Rome 19
Santa Clara 18
Ashburn 17
San Jose 17
Milan 13
Council Bluffs 9
Los Angeles 9
Bologna 6
Buffalo 5
Singapore 5
Genoa 4
Naples 4
Toronto 4
Afragola 3
Dallas 3
Hillsboro 3
Palermo 3
Princeton 3
Turin 3
Biên Hòa 2
Cardito 2
Chicago 2
Fidenza 2
Foggia 2
Itagui 2
Jacksonville 2
Kingston 2
Lissone 2
Perugia 2
Phoenix 2
San Diego 2
Verona 2
Warsaw 2
Abbeville 1
Andrews 1
Argelato 1
Arlington 1
Ascoli Piceno 1
Aseri 1
Asheville 1
Baku 1
Baldwin 1
Bari 1
Baton Rouge 1
Beacon 1
Bergamo 1
Boardman 1
Bolzano Vicentino 1
Box Springs 1
Brantford 1
Brescia 1
Brooklyn 1
Cagliari 1
Canton 1
Casalnuovo di Napoli 1
Charlotte 1
Chennai 1
Choloma 1
Città Sant'Angelo 1
Comanche 1
Comayagua 1
Cuneo 1
Da Nang 1
East Aurora 1
East Bend 1
Edgewood 1
El Cajon 1
Eustis 1
Florence 1
Fontana 1
Forest 1
Frankfurt am Main 1
Gainesville 1
Gattatico 1
Genazzano 1
Glenside 1
Goiânia 1
Guatemala City 1
Hamburg 1
Hanoi 1
Helena 1
Huntington Beach 1
Inglewood 1
Islamabad 1
Joliet 1
Kansas City 1
Kuala Lumpur 1
Lafayette 1
Las Heras 1
Lexington 1
Managua 1
Marnate 1
Mexico City 1
Milwaukee 1
Monfalcone 1
Montgomery 1
Montreal 1
Totale 355
Nome #
Clinical applications of NGF in ocular diseases 57
1953-2023. Seventy Years of the Nerve Growth Factor: A Potential Novel Treatment in Neurological Diseases? 28
The History of Nerve Growth Factor: From Molecule to Drug 26
Investigational drugs in dry eye disease 22
Vernal keratoconjunctivitis activity induces decrease of ocular surface CD14, TLR-4 and TLR-9 expression 20
New disposable esthesiometer (KeraSenseⓇ) to improve diagnosis and management of neurotrophic keratitis 15
Allergic conjunctivitis: current concepts on pathogenesis and management 14
Toll-like receptors in ocular surface diseases: overview and new findings 14
Limbal stem cell transplantation: clinical results, limits, and perspectives 13
Cytological ocular surface changes in GVHD patients 12
Hyperpigmented spots at fundus examination: a new ocular sign in neurofibromatosis type I 12
Patients with neurotrophic keratitis demonstrate alterations in ocular surface expression of transient receptor potential (TRP) channels 11
Neurotrophic factors and corneal nerve regeneration 11
Preliminary evidence of the efficacy of probiotic eye-drop treatment in patients with vernal keratoconjunctivitis 11
Health-related quality of life in children at the diagnosis of vernal keratoconjunctivitis 11
Changes of NGF pathway in allergic rhinoconjunctivitis: a conjunctival allergen challenge study 11
Molecular insights and emerging strategies for treatment of metastatic uveal melanoma 11
Effetto degli aminoacidi somministrati per via topica in pazienti con secchezza oculare 11
Tailored approach to the treatment of vernal keratoconjunctivitis 11
Long-term clinical efficacy of topical treatment with recombinant human nerve growth factor in neurotrophic keratopathy: a novel cure for a rare degenerative corneal disease? 11
In vivo antivascular endothelial growth factor treatment induces corneal endothelium apoptosis in rabbits through changes in p75NTR-proNGF pathway 10
Diagnosis and management of iridocorneal endothelial syndrome 10
Ocular surface involvement in patients with neurofibromatosis type 1 syndrome 9
Clinical and Epidemiological Study on Tubercular Uveitis in a Tertiary Eye Care Centre in Italy 9
A modified femtosecond laser technique for anterior capsule contraction syndrome 9
Le rinocongiuntiviti allergiche. 9
Evaluation of IL8 pathway on the ocular surface: new insights in patients with ocular mucous membrane pemphigoid 8
Safety and pharmacokinetics of escalating doses of human recombinant nerve growth factor eye drops in a double-masked, randomized clinical trial 8
New insights on the diagnosis and management of malignant tumors of the ocular surface 8
Understanding vernal keratoconjunctivitis: beyond allergic mechanisms 8
Demographic and clinical factors associated with development of brimonidine tartrate 0.2%-induced ocular allergy 8
Neutrotrophic Keratoconjunctivitis. 8
Diabetic retinopathy, oxidative stress and sirtuins: an in depth look in enzymatic patterns and new therapeutic horizons 8
Recombinant human nerve growth factor treatment promotes photoreceptor survival in the retinas of rats with retinitis pigmentosa 7
La cheratite neurotrofica: un caso clinico 7
Amniotic membrane transplantation associated with conjunctival peritomy in the management of Mooren's ulcer: a case report 7
Pathophysiology of corneal dystrophies: from cellular genetic alteration to clinical findings 7
Development and preliminary validation of a new screening questionnaire for identifying atopic children 7
The long-term clinical efficacy of recombinant human nerve growth factor in the treatment of neurotrophic keratitis 7
Patologia del segmento anteriore oculare 7
La cheratite neurotrofica: come riconoscerla 7
La ricerca scientifica in Italia 7
il Nerve growth factor e la superficie oculare 6
Diagnosis and management of neurotrophic keratitis 6
Thymosin Beta 4 (T{beta}4) Expression in Vernal Keratoconjunctivitis (VKC) 6
Tear levels of neuropeptides increase after specific allergen challenge in allergic conjunctivitis 6
Management of patients with Graves' disease and orbital involvement: role of spectral domain optical coherence tomography 6
Current and emerging treatment options for vernal keratoconjunctivitis 6
Diagnosis and management of neuromyelitis optica spectrum disorders - An update 6
Development and testing of the quality of life in children with vernal keratoconjunctivitis questionnaire 5
Effect of recombinant human nerve growth factor eye drops in patients with dry eye: a phase IIa, open label, multiple-dose study 5
Cocaine snorting may induce ocular surface damage through corneal sensitivity impairment 5
Nonspecific provocation of target organs in allergic diseases: EAACI-GA(2)LEN consensus report 5
Efficacy of topical nerve growth factor treatment in dogs affected by dry eye 4
Topical cyclosporine prevents seasonal recurrences of vernal keratoconjunctivitis in a randomized, double-masked, controlled 2-year study 4
Capsaicin-induced corneal sensory denervation and healing impairment are reversed by NGF treatment 4
Evidence of pepsin-related ocular surface damage and dry eye (PROD syndrome) in patients with laryngopharyngeal reflux 4
Alteration of CXCL8 pathway in the ocular surface of patients with Graves' orbitopathy 4
Involvement of ocular surface in graft-versus-host disease: An update from immunopathogenesis to treatment 4
Rare diseases of the anterior segment of the eye: update on diagnosis and management 4
Alterations of tear neuromediators in dry eye disease 4
Understanding the pathogenesis of neurotrophic keratitis: the role of corneal nerves 4
l'occhio e l'allergia: una ricerca sul campo per valutare la diffusione delle allergie nei bambini in età scolare 4
Autophagy-lysosome pathway alteration in ocular surface manifestations in Fabry disease patients 4
Congenital corneal anesthesia and neurotrophic keratitis: diagnosis and management 4
Upregulation of ICAM-1 expression in the conjunctiva of patients with chronic graft-versus-host disease 4
Quality of life and neuropsychiatric disorders in patients with Graves’ orbitopathy: current concepts 4
Analysis of the pathogenic factors and management of dry eye in ocular surface disorders 4
Tear ferning test and pathological effects on ocular surface before and after topical cyclosporine in vernal keratoconjunctivitis patients 3
Allergy screening in a schoolchildren-based population 3
Epidemiology and economic impact of moderate and severe neurotrophic keratopathy in Italy 3
Neurotrophic factors in glaucoma and innovative delivery systems 3
Choroidal neovascular membrane following hormonal stimulation for in vitro fertilization 3
Neurotrophic factors and nerve growth factor in ocular allergy 3
Evaluation of the effectiveness of BNT162b2 primary vaccination and booster dose to SARS-CoV-2 in eliciting stable mucosal immunity 3
Autoimmune diseases and the anterior segment of the eye 3
Cenegermin for the treatment of neurotrophic keratitis 3
A two-Week, randomized, double-masked study to evaluate safety and efficacy of lubricin (150 μg/mL) eye drops versus sodium hyaluronate (HA) 0.18% eye drops (Vismed®) in patients with moderate dry eye disease 3
Clinical and cytological findings in limbal stem cell deficiency 3
Long-term clinical outcome and satisfaction survey in patients with neurotrophic keratopathy after treatment with cenegermin eye drops or amniotic membrane transplantation 3
Toxic corneal ulcer: a frequent and sight-threatening disease 3
Hyperosmolar conjunctival provocation for the evaluation of nonspecific hyperreactivity in healthy patients and patients with allergy 3
Chemokine receptor CCR5 expression in conjunctival epithelium of patients with dry eye syndrome 3
Neurogenic inflammation of the ocular surface 3
SD-OCT in NIR modality to diagnose retinal microvascular abnormalities in neurofibromatosis type 1 2
Limbal stem cell deficiency associated with LADD syndrome 2
Systematic review of randomised clinical trials on topical ciclosporin A for the treatment of dry eye disease 2
Corneal changes in neurosurgically induced neurotrophic keratitis 2
Clinical grading of vernal keratoconjunctivitis 2
NGF topical application in patients with corneal ulcer does not generate circulating NGF antibodies 2
Sex hormones in allergic conjunctivitis: altered levels of circulating androgens and estrogens in children and adolescents with vernal keratoconjunctivitis 2
A closer look at nerve growth factor: From biology to clinical trials in ophthalmology 1
Nerve growth factor therapy for corneal disease 1
Topical azithromycin as a novel treatment for ocular rosacea 1
Systematic review of randomized clinical trials on safety and efficacy of pharmacological and nonpharmacological treatments for retinitis pigmentosa 1
Preliminary evidence of neuropeptides involvement in keratoconus 1
Totale 696
Categoria #
all - tutte 14.684
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.684


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/2026520 0 0 0 0 7 5 12 61 43 155 79 158
2026/2027176 53 53 24 46 0 0 0 0 0 0 0 0
Totale 696